鼻闭合术是治疗遗传性出血性毛细血管扩张症严重难治性鼻出血的有效方法吗?范围综述与叙述性综合
本范围综述系统检索过去30年Cochrane图书馆、EMBASE、PubMed及非索引文献,纳入10项研究共192例接受鼻闭合术的遗传性出血性毛细血管扩张症(HHT)患者,采用叙述性综合汇总证据。结果显示鼻闭合术可降低鼻出血严重程度、改善生活质量,部分裂开是常见并发症且通常可经翻修手术成功处理;结论强度受结局指标异质性限制。
要点
- 鼻闭合术可降低HHT相关严重难治性鼻出血的严重程度并改善生活质量。
- 部分裂开是鼻闭合术后常见并发症,通常可经翻修手术成功处理。
- 结论强度受纳入研究结局指标异质性限制。
核心结论
- 鼻闭合术可降低HHT相关严重难治性鼻出血的严重程度并改善生活质量,为最具挑战性病例提供有价值的治疗选择。
- 结论强度受结局指标异质性限制。
- 据作者所知,这是接受鼻闭合术患者的最大汇总数据库。
研究设计与样本
- 范围综述与叙述性综合,系统检索Cochrane图书馆、EMBASE、PubMed及非索引文献过去30年的文献。
- 由两名独立评价者提取数据并评估纳入研究的偏倚。
- 因纳入研究异质性采用叙述性综合汇总发现。
- 共纳入10项研究、192例接受鼻闭合术的患者。
主要发现
- 192例来自10项研究的患者接受了鼻闭合术。
- 常用结局指标为经验证的鼻出血严重程度评分、格拉斯哥获益量表(Glasgow Benefit Inventory)及血红蛋白趋势。
- 手术改善了生活质量并降低了术后鼻出血严重程度。
- 部分裂开是常报告的并发症,通常经翻修手术成功治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 结论强度受结局指标异质性限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hereditary haemorrhagic telangiectasia (HHT) is an uncommon genetic disorder characterised by recurrent, severe epistaxis which poses significant management challenges. Nasal closure has emerged as a treatment for refractory cases, however there is limited research on its outcomes. We aim to consolidate existing evidence to assess its efficacy and safety. METHODS: We conducted a systematic search of the Cochrane library, EMBASE, PubMed and non-indexed publications from the past 30 years. Two independent reviewers extracted data and assessed bias from included studies. Findings were summarised via narrative synthesis due to heterogeneity of included studies. RESULTS: 192 patients from ten studies underwent nasal closure. Frequently used outcome measures were validated epistaxis severity scores, Glasgow Benefit Inventory and haemoglobin trends. Surgery improved quality of life and reduced epistaxis severity post-operatively. Partial dehiscence is a frequently reported complication which is usually successfully treated with revision surgery. CONCLUSIONS: Nasal closure reduces epistaxis severity, improving quality of life in patients with severe, refractory HHT-related epistaxis, providing a valuable treatment option for the most challenging cases. The strength of our conclusions is limited by the heterogeneity of outcome measures. To our knowledge, this is the largest pooled database of patients who have undergone nasal closure.
引用
- Bickerton R, Gera R, Ross T, et al. Is nasal closure an effective treatment for severe refractory epistaxis in HHT? A scoping review and narrative synthesis. Rhinology. 2025. PMID: 39907212. doi:10.4193/Rhin24.448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。